BIOME AUSTRALIA ORD
Biome Australia Extends Exclusive Probiotical Supply Agreement Through 2028
Biome Australia extends exclusive Probiotical supply to 2028, securing supply amid expansion; H1 FY2026 revenue $12.4m, EBITDA-positive.
Biome Australia Surges with 41% YoY Revenue Growth in Q2 FY26
Biome Australia (ASX: BIO) has reported a robust Q2 FY26, with revenue surging 40.9% year-on-year to $6.48 million, significantly exceeding expectations and reinforcing its trajectory towards its 'Vis
Biome Australia Launches First Human Clinical Trial on Proprietary BMB18 Strain
Biome Australia (ASX: BIO) has submitted ethics approval and registered its first human clinical trial on proprietary probiotic strain Lactobacillus plantarum BMB18 with the Australia New Zealand Clinical Trials Registry.
Biome Australia Expands Retail Distribution with Mecca and Go Vita Partnerships
Biome Australia (ASX: BIO) has struck new distribution agreements with Mecca and Go Vita, marking a significant expansion for its flagship Activated Probiotics range into both premium beauty and mainstream health food retail. The company said the partnerships represent a turning point in its distribution strategy, extending reach into high-traffic retail environments while reinforcing its […]